Edwards Lifesciences (EW) Notes Payables (2009 - 2014)

Edwards Lifesciences' Notes Payables history runs 4 years deep, the most recent figure standing at $2.6 million for Q4 2014.

• On a quarterly basis, Notes Payables fell 80.15% year-over-year to $2.6 million in Q4 2014; TTM through Dec 2014 was $2.6 million, a 80.15% decrease from a year earlier, with the FY2014 full-year figure at $2.6 million, down 80.15% from the prior year.
• Notes Payables climbed to $2.6 million in Q4 2014 per EW's latest filing, from $2.2 million in the prior quarter.
• Across five years, Notes Payables topped out at $14.7 million in Q4 2010 and bottomed at $2.2 million in Q3 2014.
• The 3-year median for Notes Payables is $7.8 million (2013), against an average of $8.2 million.
• Across the five-year window, Notes Payables soared 390.0% in 2010 and tumbled 80.15% in 2014, its largest moves.
• Year by year, Notes Payables stood at $14.7 million in 2010, then slipped by 10.88% to $13.1 million in 2013, then tumbled by 80.15% to $2.6 million in 2014.
• Per Business Quant, the three latest EW Notes Payables figures stand at $2.6 million (Q4 2014), $2.2 million (Q3 2014), and $13.1 million (Q4 2013).